详情描述
CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor.
Product information
CAS Number: 1415834-63-7
Molecular Weight: 388.80
Formula: C20H15ClF2N2O2
Chemical Name: N-(4-((4-chlorobenzyl)oxy)pyridin-2-yl)-2-(2, 6-difluorophenyl)acetamide
Smiles: O=C(CC1C(F)=CC=CC=1F)NC1=CC(=CC=N1)OCC1C=CC(Cl)=CC=1
InChiKey: GISJHCLTIVIGLX-UHFFFAOYSA-N
InChi: InChI=1S/C20H15ClF2N2O2/c21-14-6-4-13(5-7-14)12-27-15-8-9-24-19(10-15)25-20(26)11-16-17(22)2-1-3-18(16)23/h1-10H,11-12H2,(H,24,25,26)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO : ≥ 50 mg/mL (128.60 mM)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
CPDA enhances insulin signaling.
In Vivo:
CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice.
References:
- Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2). Eur J Med Chem. 2013 Apr;62:649-660.
Products are for research use only. Not for human use.